biote Corp. Reports Executive/Director Changes & Compensation on Jan 8
Ticker: BTMD · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1819253
Complexity: simple
Sentiment: neutral
Topics: executive-changes, corporate-governance, compensation
TL;DR
**biote Corp. just reported executive/director changes and compensation details, watch for strategic shifts.**
AI Summary
biote Corp. filed an 8-K on January 11, 2024, reporting an event that occurred on January 8, 2024. This filing indicates changes related to the departure or election of directors, appointment of officers, or compensatory arrangements for officers, as well as Regulation FD Disclosure and Financial Statements and Exhibits. For investors, this matters because changes in leadership or executive compensation can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.
Why It Matters
Changes in a company's leadership or executive compensation can significantly influence its strategic direction and operational efficiency, directly affecting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty, but the specific details of the changes are not provided in this summary, making the exact impact unclear.
Analyst Insight
A smart investor would monitor biote Corp.'s subsequent filings and press releases for specific details on the executive and director changes, as these will clarify the strategic implications and potential impact on the company's future performance.
Key Numbers
- $0.0001 — Par Value per Share (Par value of biote Corp.'s Class A common stock)
Key Players & Entities
- biote Corp. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — date of the earliest event reported
- January 11, 2024 (date) — date the 8-K was filed
- 001-40128 (other) — Commission File Number
- $0.0001 (dollar_amount) — par value per share of Class A common stock
- BTMD (other) — Trading Symbol for Class A common stock
- The Nasdaq Stock Market LLC (other) — exchange where Class A common stock is registered
Forward-Looking Statements
- Further details regarding the specific executive or director changes and compensation arrangements will be disclosed in subsequent filings or company communications. (biote Corp.) — high confidence, target: Q1 2024
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 8, 2024.
What specific items were reported under Item Information in this 8-K?
The 8-K reported information under 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.
What is the trading symbol and exchange for biote Corp.'s Class A common stock?
biote Corp.'s Class A common stock trades under the symbol BTMD on The Nasdaq Stock Market LLC.
What is the par value of biote Corp.'s Class A common stock?
The par value of biote Corp.'s Class A common stock is $0.0001 per share.
When was biote Corp. formerly known as Haymaker Acquisition Corp. III?
biote Corp. was formerly known as Haymaker Acquisition Corp. III, with the name change occurring on July 27, 2020.
Filing Stats: 1,222 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-01-11 16:37:00
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share BTMD The Nasdaq Stock Mar
- $425,000 — ed to: (i) an annualized base salary of $425,000 per year; (ii) annual bonus up to 50% o
- $177,000 — of (a) restricted stock units valued at $177,000 and (b) 400,000 options to purchase sha
- $140,000 — t and will be eligible to receive up to $140,000 as an additional severance benefit, sub
Filing Documents
- d715175d8k.htm (8-K) — 28KB
- d715175dex991.htm (EX-99.1) — 9KB
- g715175g57b09.gif (GRAPHIC) — 5KB
- 0001193125-24-006634.txt ( ) — 170KB
- btmd-20240108.xsd (EX-101.SCH) — 3KB
- btmd-20240108_lab.xml (EX-101.LAB) — 18KB
- btmd-20240108_pre.xml (EX-101.PRE) — 11KB
- d715175d8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 11, 2024, the Company issued a press release with respect to the management changes described in Item 5.02 of this Current Report on Form 8-K. A copy of the Company's press release is being furnished as Exhibit 99.1 to this Form 8-K. The exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated January 11, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOTE CORP. By: /s/ Teresa S. Weber Name: Teresa S. Weber Title: Chief Executive Officer Date: January 11, 2024